Synexa Life Sciences is pleased to announce Sally Hannam as the latest addition to the Synexa Life Sciences’ Scientific Strategies Team, taking on the role of Scientific Director.
With a career spanning more than three decades, Sally is a recognised leader in liquid chromatography-mass spectrometry (LC-MS), specialising in the development and validation of bioanalytical assays. Her expertise encompasses a wide range of applications, from small molecules to complex biomolecules, all under the strictest regulatory frameworks including GLP and GCP.
Sally’s journey includes being a co-founder of Alderley Analytical, where she played a pivotal role in establishing the company as a trusted player in the bioanalytical field. Her work in ensuring scientific excellence and compliance was key to the company’s growth, leading to its acquisition by Synexa Life Sciences in October 2024. A graduate in Applied Biology from the University of the West of England, Sally has always been driven by a passion for advancing scientific understanding and improving analytical techniques.
In her new role at Synexa as part of the the Scientific Strategies Team, Sally will work closely with Synexa’s customers and scientists, continuing to help steer the development of leading bioanalytical solutions.
